Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Carotid ultrasound to predict blood pressure drops during dialysis

Official title: The Predictive Value of Carotid Corrected Flow Time and Peak Flow Velocity Variability for Intradialytic Hypotension: A Prospective Multicenter Observational Study

Run by First Affiliated Hospital of Wannan Medical College · NCT07033260 · Data updated 2026-11-12

We're testing whether carotid ultrasound measurements can help predict which adults on long-term hemodialysis will have drops in blood pressure during treatment.

More Hemodialysis trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment183 (estimated)
SponsorFirst Affiliated Hospital of Wannan Medical College
Academic / other
Locations1 site (Wuhu, Outside of the US)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedAugust 30, 2025
Study endsAugust 30, 2025
Registry record updatedJune 24, 2025
Trial IDNCT07033260 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with end-stage renal disease who have been on maintenance hemodialysis for at least three months and can undergo carotid ultrasound and give informed consent.

Probably not a fit

Patients with significant carotid stenosis, unstable cardiovascular status, major arrhythmias, inability to receive ultrasound, or those taking antihypertensive medications during dialysis are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter prospective observational study will enroll adults with end-stage renal disease receiving maintenance hemodialysis to measure carotid corrected flow time (FTc) and peak flow velocity variability (PFVV). Ultrasound assessments will be performed once at about one hour after dialysis initiation while blood pressure is continuously monitored during the session. The primary analysis will determine the sensitivity, specificity, and optimal cutoff points of FTc and PFVV for predicting intradialytic hypotension. Patients with major carotid stenosis, significant arrhythmias, hemodynamic instability, or inability to undergo ultrasound are excluded.

Why it matters

Potential benefit: If successful, this could allow clinicians to identify patients at high risk for intradialytic hypotension and take preventive steps during dialysis.

How similar studies have gone: Small prior studies and physiologic data support a link between carotid flow measures and volume or hemodynamic status, but large multicenter validations are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults aged 18 to 80 years. Diagnosed with end-stage renal disease (ESRD). Undergoing maintenance hemodialysis for more than three months. Willing and able to provide informed consent and comply with study procedures.

Exclusion Criteria:

Patients with significant carotid artery stenosis due to heavy atherosclerotic plaque (defined as more than 70% stenosis confirmed by ultrasound or angiography).

Hemodynamically unstable patients or those requiring vasopressor support. Patients with significant arrhythmias (e.g., atrial fibrillation, ventricular tachycardia).

Dialysis sessions terminated for reasons unrelated to hypotension (e.g., technical issues, patient request).

Use of antihypertensive medications during dialysis sessions. Inability to undergo ultrasound assessment due to factors such as severe obesity or wounds obstructing access.

Patients who withdraw informed consent during the study.

Where it's running

  • The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)
    Wuhu, Outside of the US, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.